Araştırma Makalesi

Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment

Sayı: Advanced Online Publication Erken Görünüm Tarihi: 13 Kasım 2026
PDF İndir
EN TR

Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment

Öz

Objective: Osteoid osteoma causes intense nocturnal pain that severely disrupts sleep. Although pain relief after definitive treatment is well known, the magnitude and clinical meaningfulness of sleep improvement remain unquantified. We aimed to establish disease-specific patient-reported benchmarks for sleep recovery after treatment for osteoid osteoma.
Materials and Methods: Retrospective analysis of a prospectively maintained database with a prospective follow-up component for anchor-based analysis. Twenty-seven patients (median age, 22 years) treated surgically or with radiofrequency ablation were assessed using the PROMIS Sleep Disturbance Short Form 8b at baseline, 6 months, and 12 months. Longitudinal change was analyzed via a linear mixed-effects model, and anchor-based receiver operating characteristic (ROC) analysis was used to determine MCID, SCB, and PASS thresholds.
Results: Median PROMIS T-scores improved from 63.7 (IQR 62.6-64.9) preoperatively to 28.9 (IQR 28.9-35.9) at 12 months (β=-0.61; p<0.001). The anchor-based MCID was a decrease ≥18.0 points, the SCB ≥28.1 points, and the PASS ≤47.4. Overall, 81.5% achieved at least MCID and 74% achieved SCB.
Conclusion: Definitive treatment yields profound and sustained improvement in sleep quality. These preliminary benchmarks, which require external validation in larger cohorts, reflect the near-total symptom resolution unique to this condition and highlight the need for disease-specific patient-reported outcome measures.

Anahtar Kelimeler

Etik Beyan

Ethical approval for this study was obtained from the University of Health Sciences Türkiye, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Non-Interventional Clinical Research Ethics Committee (approval no: 2025-07/107; date: June 26, 2025).

Kaynakça

  1. Iyer RS, Chapman T, Chew FS. Pediatric Bone Imaging: Diagnostic Imaging of Osteoid Osteoma. Am J Roentgenol. 2012;198(5):1039-52.
  2. Kransdorf MJ, Stull MA, Gilkey FW, Moser RP. Osteoid osteoma. RadioGraphics. 1991;11(4):671-96.
  3. Parmeggiani A, Martella C, Ceccarelli L, Miceli M, Spinnato P, Facchini G. Osteoid osteoma: which is the best mininvasive treatment option? Eur J Orthop Surg Traumatol. 2021;31(8):1611-24.
  4. Lee EH, Shafi M, Hui JHP. Osteoid Osteoma. J Pediatr Orthop. 2006;26(5):695-700.
  5. De Filippo M, Russo U, Papapietro V, Ceccarelli F, Pogliacomi F, Vaienti E, et al. Radiofrequency ablation of osteoid osteoma. Acta Biomed. 2018;89(1-S):175-85.
  6. Ebrahim FS, Jacobson JA, Lin J, Housner JA, Hayes CW, Resnick D. Intraarticular Osteoid Osteoma. Am J Roentgenol. 2001;177(6):1391-5.
  7. Swee RG, McLeod RA, Beabout JW. Osteoid Osteoma. Radiology. 1979;130(1):117-23.
  8. Abdalla BA, Abdullah HO, Nasralla HA, Ali RM, Omar SS, Ghafour AK, et al. The efficacy and safety of microwave ablation in managing osteoid osteoma: a systematic review. Case Reports Plast Surg Hand Surg. 2025;12(1):2503195.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Ortopedi

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

13 Kasım 2026

Yayımlanma Tarihi

-

Gönderilme Tarihi

11 Temmuz 2026

Kabul Tarihi

13 Ekim 2026

Yayımlandığı Sayı

Yıl 2026 Sayı: Advanced Online Publication

Kaynak Göster

APA
Yaş, S., Ahmadov, A., Türkoğlu, B., Bircan, R., Kaya, İ., Atalay, İ. B., & Ulucaköy, C. (2026). Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi, Advanced Online Publication. https://doi.org/10.35440/hutfd.1992356
AMA
1.Yaş S, Ahmadov A, Türkoğlu B, vd. Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi. 2026;(Advanced Online Publication). doi:10.35440/hutfd.1992356
Chicago
Yaş, Semih, Asim Ahmadov, Buğra Türkoğlu, vd. 2026. “Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment”. Harran Üniversitesi Tıp Fakültesi Dergisi, sy Advanced Online Publication. https://doi.org/10.35440/hutfd.1992356.
EndNote
Yaş S, Ahmadov A, Türkoğlu B, Bircan R, Kaya İ, Atalay İB, Ulucaköy C (13 Kasım 2026) Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi Advanced Online Publication
IEEE
[1]S. Yaş vd., “Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment”, Harran Üniversitesi Tıp Fakültesi Dergisi, sy Advanced Online Publication, Kas. 2026, doi: 10.35440/hutfd.1992356.
ISNAD
Yaş, Semih - Ahmadov, Asim - Türkoğlu, Buğra - Bircan, Resul - Kaya, İbrahim - Atalay, İsmail Burak - Ulucaköy, Coşkun. “Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment”. Harran Üniversitesi Tıp Fakültesi Dergisi. Advanced Online Publication (13 Kasım 2026). https://doi.org/10.35440/hutfd.1992356.
JAMA
1.Yaş S, Ahmadov A, Türkoğlu B, Bircan R, Kaya İ, Atalay İB, Ulucaköy C. Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi. 2026. doi:10.35440/hutfd.1992356.
MLA
Yaş, Semih, vd. “Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment”. Harran Üniversitesi Tıp Fakültesi Dergisi, sy Advanced Online Publication, Kasım 2026, doi:10.35440/hutfd.1992356.
Vancouver
1.Semih Yaş, Asim Ahmadov, Buğra Türkoğlu, Resul Bircan, İbrahim Kaya, İsmail Burak Atalay, Coşkun Ulucaköy. Minimal Clinically Important Difference for PROMIS Sleep Disturbance After Osteoid Osteoma Treatment. Harran Üniversitesi Tıp Fakültesi Dergisi. 13 Kasım 2026;(Advanced Online Publication). doi:10.35440/hutfd.1992356

Bu dergide yayınlanan makaleler Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 (CC-BY-NC-SA 4.0) Uluslararası Lisansı ile lisanslanmıştır.